The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / October / Gold-Based Sensor Finds Bugs, Fast
Microbiology & Immunology Infectious Disease Point of care testing Screening and monitoring Technology and innovation

Gold-Based Sensor Finds Bugs, Fast

New filtration technique detects low concentrations of bacteria and assesses antibiotic susceptibility, offering a potential faster route to diagnosing sepsis and other serious infections

10/30/2026 News 2 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Scorecard
  • Quiz
  • Poll

Share

5 Key Takeaways
  • 1

    Researchers developed a filtration-based SERS platform that captures bacteria on a gold-coated glass microfiber filter and amplifies their molecular signals with additional gold particles.

  • 2

    In tests using Escherichia coli, the platform captured more than 99.9% of bacteria at the concentrations tested and detected levels as low as 1,000 CFU/mL.

  • 3

    A 1-hour culture step improved the platform’s detection sensitivity to 10 CFU/mL.

  • 4

    The platform distinguished Escherichia coli, Staphylococcus aureus, and Klebsiella pneumoniae by their molecular fingerprints.

  • 5

    In Escherichia coli tests, antibiotic responses to amikacin and ampicillin were distinguishable within 2 hours, but validation with patient blood samples and more pathogens remains necessary.

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.